Publication | Closed Access

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

NanomedicineOncologyPancreatic CancerMedicineFolinic AcidPrevious Gemcitabine-based TherapyTumor TargetingMetastatic Pancreatic CancerCancer TreatmentPharmacologyRadiation Oncology